When was Naari founded?

Naari was founded in 2007 and raised its 1st funding round 12 years after it was founded.

Where is Naari located?

Naari is headquartered in Noida, India. It is registered at Plot No.30, Galaxy, 1st Main Road JP Nagar, Third Phase, Bangalore, Bangalore, Karnataka, India, 560078.

Who is the current CEO of Naari?

Prithi S Kochhar and Gulveen Kochhar s of Naari. Prithi S Kochhar has also founded 1 company.

Which legal entities is Naari associated with?

Naari is associated with NAARI PHARMA PRIVATE LIMITED.

How many employees does Naari have?

As of Aug 31, 2025, Naari has 193 employees, reflecting a 4% year-over-year growth in headcount.

Is Naari a funded company?

Naari is a funded company, having raised a total of $19M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Oct 03, 2019.

How much is Naari worth?

The last known valuation of Naari was $***** as of Jan 07, 2021.

When was the latest funding round of Naari?

Naari's latest funding was a $***** PE round on Dec 06, 2019, with participation from 1 investor. Its primary sector is Women Health. Globally, the Women Health sector has seen $236M in funding in 2026 to date.

What is the annual revenue of Naari?

Annual revenue of Naari is between ₹100 Cr and ₹500 Cr as on Mar 31, 2025

Where does Naari rank among its competitors?

Naari ranks 5th amongst 41 active competitors, of which 11 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Rejoni, which secured $25M in Jun, 2026.

Who are the top competitors of Naari?

Naari's top competitors include Rejoni, Sprout Pharmaceuticals and Gameto. Among them, Rejoni secured the most recent funding round in June, 2026.

Naari - 2026 Company Profile, Team, Funding, Competitors & Financials

Naari is an acquired company based in Noida (India), founded in 2007 by Prithi S Kochhar. It operates as a Manufacturer of women care medicines. Naari has raised $19M in funding from Ascent Capital and Jagsonpal, with last known valuation of $*****. The company has 41 active competitors, including 11 funded and 7 that have exited. Its top competitors include companies like Rejoni, Sprout Pharmaceuticals and Gameto.

Company Details

Website: naari.co
Phone Number: +91 **********
Registered Address: Plot No.30, Galaxy, 1st Main Road JP Nagar, Third Phase, Bangalore, Bangalore, Karnataka, India, 560078

Key Metrics

Founded Year

2007

Location

Noida, India

Stage

Acquired

Total Funding

$19M in 2 rounds

Latest Funding Round

PE, Dec 06, 2019, $*****

Last Known Valuation

$***** as on Jan 07, 2021

Investors

Ascent Capital & 19 more

Ranked

5^th among 41 active competitors

Annual Revenue

₹100 - ₹500 Cr as on Mar 31, 2025

Employee Count

193 as on Aug 31, 2025

Similar Companies

Rejoni & 40 more

Exit Details

Acquired by Tenshi Life Sciences (May 01, 2017)

View Naari's full profile

Naari is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
NAARI PHARMA PRIVATE LIMITED CIN: U74899KA1978PTC142872 , India, Active	Feb 23, 1978	₹100 - ₹500 Cr (As on Mar 31, 2025)	213 (As on Mar 01, 2026)

Naari got acquired by Tenshi Life Sciences on May 01, 2017.

Click here to take a look at Naari's acquisition in detail

Naari has raised a total funding of $19M over 2 rounds. Its first funding round was on Oct 03, 2019. Its latest funding round was a PE round on Dec 06, 2019 for $*****. 1 investor participated in its latest round. Naari has 4 institutional investors and 16 angel investors.

Here is the list of recent funding rounds of Naari:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 06, 2019	8138255	PE	7183654	6348901	7207546	9351953
Oct 03, 2019	8790262	Series A	9809147	6559997	Jagsonpal	5203966

Access funding benchmarks and valuations. Sign up today!

View details of Naari's funding rounds and investors

The founders of Naari is Prithi S Kochhar. Prithi S Kochhar and Gulveen Kochhar are the CEOs of Naari.

Here are the details of Naari's key team members:

Prithi S Kochhar: Co-Founder & Co-CEO of Naari.
Contact Info: 1 email address and 1 phone number
Gulveen Kochhar: Co-CEO of Naari.

View details of Naari's Founder profiles and Board Members

Naari's employee count trend

Naari has 193 employees as of Aug 25. The total employee count is 3.0% more than what it was in Aug 24. Here is Naari's employee count trend over the years:

Uncover Naari's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Naari include Rejoni, Sprout Pharmaceuticals and Gameto. Here is the list of Top 10 competitors of Naari, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Rejoni 2020, Bedford (United States), Series B	Developer of therapeutics to treat women health conditions	$66.3M	Ascension Ventures, CHV & 8 others	61/100
2nd	Sprout Pharmaceuticals 2011, Raleigh (United States), Acquired	Developer of drugs for hypoactive sexual desire disorder in women	$185M	New Ventures Funds, Lunsford Capital & 1 others	57/100
3rd	Gameto 2020, United States, Series C	Developer of therapeutics for the treatment of fertility and menopause	$127M	RA Capital Management, Two Sigma Ventures ... & 30 others	57/100
4th	Hope Medicine 2018, Shanghai (China), Series B	Developer of monoclonal antibodies for the treatment of multiple diseases	$56M	Qiming Venture Partners, Ennovation Ventures ... & 7 others	56/100
5th	Naari 2007, Noida (India), Acquired	Manufacturer of women care medicines	$19M	Ascent Capital, Aresko & 18 others	52/100
6th	FimmCyte 2022, Basel (Switzerland), Funding Raised	Developer of therapeutics to treat endometriosis	-	BaseLaunch, Venture Kick & 2 others	45/100
7th	PregLem 2006, Geneva (Switzerland), Acquired	Drugs for women's reproductive medicine	$57.9M	MVM, NeoMed & 2 others	44/100
8th	ObsEva 2012, Geneva (Switzerland), Public	Developer of therapeutics for women's reproductive health and pregnancy	$94.7M	Sofinnova Partners, Rock Springs Capital ... & 17 others	44/100
9th	Forendo Pharma 2013, Turku (Finland), Acquired	Provider of small molecule based therapeutics for reproductive health	$25.6M	Sunstone, Novo Holdings & 8 others	44/100
10th	Aptorum Group 2017, London (United Kingdom), Public	Developer of small molecular therapeutics for multiple disorders	-	Aenco	43/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Naari's competitors? Click here to see the top ones

Funds own 19.24%, Parent Entities (largest shareholder) own 48.46%, Enterprises own 3.22% and Other People own 29.08%. The cap table displayed below is for NAARI PHARMA PRIVATE LIMITED which is the legal entity associated with Naari.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Fund	19.24%	125Cr	9046440	3620782	7261344	2182267
Ascent Capital	1023041	8081982	6666082	5196060	1558578	4674804
Parent Entity	48.46%	315Cr	1838918	4998218	4899655	9532304
Enterprise	3.22%	20.9Cr	178	654	573	198
Other People	29.08%	189Cr	9549194	6457134	8630905	5784464
Total	100.00%	650Cr	8470531	8658991	9233125	7800324